KBC Group
SCLN

KBC Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

KBC Group’s Portfolio SCLN Stock Details SCLN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
2017
Q3 		$383K Buy
2016
Q3 		– Sell
2016
Q2 		$152K Hold
2016
Q1 		$128K Hold
2015
Q4 		$107K Hold
2015
Q3 		$81K Sell
2015
Q2 		$173K Sell
2015
Q1 		$206K Buy